Darunavir Krka

Krka is a leading international generic pharmaceutical company headquartered in Slovenia, specializing in the development and production of high-quality generic prescription drugs. The company's extensive portfolio includes treatments for cardiovascular diseases, central nervous system disorders, gastrointestinal conditions, and infectious diseases, including HIV. Krka operates a vertically integrated business model, managing everything from R&D and API synthesis to final dosage form manufacturing and global marketing. With a presence in over 70 markets, it is particularly strong in Central, Eastern, and South-Eastern Europe, providing affordable alternatives to major branded medications.